Aprogen Biologics Revenue

In the year 2024, Aprogen Biologics had annual revenue of 67.38B KRW, down -22.88%. Aprogen Biologics had revenue of 22.05B in the quarter ending December 31, 2024, a decrease of -2.88%.

Revenue

67.38B

Revenue Growth

-22.88%

P/S Ratio

3.31

Revenue / Employee

178.72M

Employees

377

Market Cap

223.29B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	67.38B	-19.99B	-22.88%
Dec 31, 2023	87.36B	22.17B	34.01%
Dec 31, 2022	65.19B	8.71B	15.42%
Dec 31, 2021	56.48B	3.16B	5.93%
Dec 31, 2020	53.32B	2.42B	4.75%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	4,547.32B
Celltrion	3,557.30B
ALTEOGEN	102.85B
Yuhan	2,067.79B
SK Biopharmaceuticals	547.60B
HLB Co., Ltd.	68.13B
LigaChem Biosciences	125.90B
PharmaResearch	350.12B

Revenue Rankings